Mrv0541 02231216302D 8 8 0 0 0 0 999 V2000 -0.1467 2.3518 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 0.5678 1.9393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2822 2.3518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.5678 1.1143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2352 0.6294 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 0.9803 -0.1553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1553 -0.1553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0997 0.6294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 2 4 1 0 0 0 0 4 5 2 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 4 8 1 0 0 0 0 M CHG 2 1 -1 5 1 M END > DB02838 > drugbank > [O-]C(=O)C1=[NH+]CCC1 > InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h1-3H2,(H,7,8) > RHTAIKJZSXNELN-UHFFFAOYSA-N > C5H7NO2 > 113.1146 > 113.047678473 > 2 > 15 > -0.3155153139750355 > 10.81138734712021 > 1 > 1 > 0 > 0 > 3,4-dihydro-2H-pyrrol-1-ium-5-carboxylate > 0.38 > 0.5292144963333332 > -0.85 > 0 > 0 > 1 > 0 > 3.9331828370415765 > 1.7241099274971199 > 54.099999999999994 > 49.890800000000006 > 1 > 1 > 2.36e+01 g/l > tetrahydrofolic acid > 0 > DB02838 > EXPT00141 > experimental > 3,4-Dihydro-2h-Pyrrolium-5-Carboxylate $$$$